Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO)’s stock price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.39 and traded as low as $1.16. Northwest Biotherapeutics shares last traded at $1.20, with a volume of 976,930 shares traded.
The business has a 50 day simple moving average of $1.25 and a 200-day simple moving average of $1.39.
Northwest Biotherapeutics (OTCMKTS:NWBO) last issued its quarterly earnings results on Monday, August 16th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.42 million during the quarter.
Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L.
Featured Story: Why are percentage gainers important?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.